The Ethereum Foundation emphasized that privacy and security should be addressed together to better protect users' onchain transaction histories from attackers. This stance follows multiple hacks and vulnerabilities reported in the past week. The Foundation highlighted its Kohaku wallet privacy initiative, which is maturing and now integrates with privacy tools like Tornado Cash, Railgun, and Privacy Pools. These integrations aim to enhance default wallet protections and reduce risks for users in the evolving blockchain environment.
The Ethereum Foundation's focus on privacy and security comes amid ongoing blockchain challenges. For readers following major cryptocurrencies, here is Pluang's market snapshot as of Oct 27, 2026 07:02 WIB: out of 50 priced major cryptocurrencies, 28 rose and 20 fell today. Notable movers include UNI (Uniswap) at Rp128.848 with a 1-day change of +3.30% and a Pluang order activity of 37% Sell / 63% Buy, ENJ (Enjin Coin) at Rp456 with +2.94% and 31% Sell / 69% Buy, and VET (VeChain) at Rp118 with -2.92% and 91% Sell / 9% Buy.
Monteverde & Associates PC is investigating the fairness of proposed mergers involving Synaptics (SYNA), Eagle Financial Services (EFSI), Victory Capital Holdings (VCTR), and Centerspace (CSR). Shareholders are urged to consider if the deals are fair...
At the Cisco Partner Summit 2026, Presidio was honored as the Global Innovation Partner of the Year, recognizing its outstanding innovation and success in delivering impactful customer solutions. This award highlights Presidio's commitment to partner...
Presidio was awarded the Global Services and Software Excellence Partner of the Year at the Cisco Partner Summit 2026. This award recognizes Presidio's outstanding innovation and success in delivering solutions that help customers achieve meaningful ...
Exodus Movement, a self-custodial finance and payments platform, will release its third quarter 2026 financial results after market close on November 9, 2026. The company will host a webcast at 5:00 PM ET the same day to discuss the results. Founded ...
Onco360, a leading independent specialty pharmacy, has been selected by AstraZeneca as a national pharmacy partner for Zegfrovy (sunvozertinib), a treatment for advanced non-small cell lung cancer with EGFR exon 20 insertion mutations. Zegfrovy has s...
